These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 9686623)
1. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623 [TBL] [Abstract][Full Text] [Related]
2. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis. Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971 [TBL] [Abstract][Full Text] [Related]
3. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196 [TBL] [Abstract][Full Text] [Related]
4. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer. Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684 [TBL] [Abstract][Full Text] [Related]
5. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes. Yoshikawa N; Noda K; Shinoda H; Uchida A; Ozawa Y; Tsubota K; Mashima Y; Ishida S J Diabetes Complications; 2013; 27(2):162-6. PubMed ID: 23062326 [TBL] [Abstract][Full Text] [Related]
6. Human vascular adhesion proteın-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease. Kemik O; Sümer A; Kemik AS; Itik V; Dulger AC; Purisa S; Tuzun S World J Surg Oncol; 2010 Sep; 8():83. PubMed ID: 20849600 [TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. Yoong KF; McNab G; Hübscher SG; Adams DH J Immunol; 1998 Apr; 160(8):3978-88. PubMed ID: 9558106 [TBL] [Abstract][Full Text] [Related]
8. Increased circulating soluble vascular adhesion protein-1 levels in systemic sclerosis: association with lower frequency and severity of interstitial lung disease. Yanaba K; Yoshizaki A; Muroi E; Ogawa F; Shimizu K; Sato S Int J Rheum Dis; 2013 Aug; 16(4):442-7. PubMed ID: 23992266 [TBL] [Abstract][Full Text] [Related]
9. Vascular adhesion protein-1 in human ischaemic stroke. Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095 [TBL] [Abstract][Full Text] [Related]
10. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease. Koutroubakis IE; Petinaki E; Vardas E; Dimoulios P; Roussomoustakaki M; Maniatis AN; Kouroumalis EA Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):405-8. PubMed ID: 11943954 [TBL] [Abstract][Full Text] [Related]
11. Expression of vascular adhesion protein-1 in atopic eczema. Madej A; Reich A; Orda A; Szepietowski JC Int Arch Allergy Immunol; 2006; 139(2):114-21. PubMed ID: 16361866 [TBL] [Abstract][Full Text] [Related]
12. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models. Salmi M; Jalkanen S Eur J Immunol; 1995 Oct; 25(10):2803-12. PubMed ID: 7589075 [TBL] [Abstract][Full Text] [Related]
17. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. Airas L; Mikkola J; Vainio JM; Elovaara I; Smith DJ J Neuroimmunol; 2006 Aug; 177(1-2):132-5. PubMed ID: 16806498 [TBL] [Abstract][Full Text] [Related]
18. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1). Arvilommi AM; Salmi M; Kalimo K; Jalkanen S Eur J Immunol; 1996 Apr; 26(4):825-33. PubMed ID: 8625974 [TBL] [Abstract][Full Text] [Related]
20. The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes. Salmi M; Hellman J; Jalkanen S J Immunol; 1998 Jun; 160(11):5629-36. PubMed ID: 9605169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]